Boston Scientific Sued J&J Unit Over Patent
Boston Scientific initiated a lawsuit against Atraverse Medical regarding alleged patent infringement.
Updated on Oct. 9, 2026 in Healthcare
Boston Scientific filed a lawsuit in the District Court of Delaware on 11 July 2026 against Atraverse Medical. The complaint alleges that the Hotwire guidewire device infringes on Patent '955.
Why it matters
The dispute centers on access to the left atrium, a critical step for performing atrial fibrillation ablation procedures. The outcome could impact the competitive landscape for companies operating within the electrophysiology market.
The electrophysiology ablation catheter market is projected to reach $17.6 billion in 2035, growing from a 2025 valuation of $6.1 billion. The sector currently features a 25.6% US market share for Boston Scientific compared to 24.6% for Medtronic.
The players
Boston Scientific
This global medical technology corporation specializes in devices for interventional medical specialties.
Atraverse Medical
This medical device firm, now a subsidiary of Johnson and Johnson, developed the Hotwire system.
Johnson and Johnson
This multinational healthcare corporation acquired Atraverse Medical in 2026 to expand its medical device portfolio.
The details
Boston Scientific alleges that the Hotwire system, which uses radiofrequency energy for transseptal catheterisation, violates its patent claims. The company claims Atraverse Medical encouraged physicians to use the device in a manner that infringes upon these established rights.
Timeline
December 2025: Atraverse Medical received FDA clearance for the Hotwire system.
April 2026: Johnson and Johnson completed the acquisition of Atraverse Medical.
11 July 2026: Boston Scientific officially filed the lawsuit in Delaware.
September 2026: Boston Scientific notified Atraverse Medical counsel of the infringement.
8 October 2026: The legal action was made public.
Market Landscape
This litigation highlights the fierce competition for dominance within the projected $17.6 billion electrophysiology ablation catheter market. The move reflects a broader trend of legal challenges used by established industry leaders to maintain market share against newer entrants.
Patients and healthcare providers may see changes to device availability or pricing depending on the court ruling. The litigation could ultimately influence the standard of care for atrial fibrillation procedures across the country.
The takeaway
Patent disputes remain a common feature in the highly competitive medical device industry. Companies often rely on intellectual property litigation to protect innovations that serve as the foundation for high-growth medical procedures.
Further reading
For additional context on the sector, visit the Healthcare industry page.
